Antibacterial R&D incentives

被引：0

作者：

Ramanan Laxminarayan

John H. Powers

机构：

[1] Ramanan Laxminarayan is at the Center for Disease Dynamics,

[2] Economics & Policy,undefined

[3] 1616 P St.,undefined

[4] NW Ste 600,undefined

[5] Washington,undefined

[6] DC 20036,undefined

[7] USA,undefined

[8] and Princeton University,undefined

[9] Princeton,undefined

[10] New Jersey 08544,undefined

[11] USA.,undefined

[12] John H. Powers is Associate Clinical Professor of Medicine at George Washington University School of Medicine,undefined

[13] 18511 Fiddleleaf Terrace,undefined

[14] Olney,undefined

[15] Maryland 20832,undefined

[16] USA.,undefined

来源：

Nature Reviews Drug Discovery | 2011年 / 10卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：727 / 728

页数：1

共 5 条

[1] Kesselheim AS(2010)Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals Health Aff. 29 1689-1696
[2] Outterson K(2008)Impact of conjugate pneumococcal vaccines on antibiotic resistance Lancet Infect. Dis. 8 785-795
[3] Dagan R(2007)Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs Clin. Infect. Dis. 45 S153-S162
[4] Klugman KP(undefined)undefined undefined undefined undefined-undefined
[5] Powers JH(undefined)undefined undefined undefined undefined-undefined